Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
- Not stated
- Not stated
- Not stated
- Not stated
Official announcement on the NIH Guide · opens the funder's page. Always confirm dates there.
Or read the full text and all 3 review criteria here, free with an account. Create free account
Summary
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) along with other participating Institutes encourages submission of applications proposing to conduct secondary data analysis and integration of existing datasets and database resources, with the ultimate aim to elucidate cancer risk and related…
Related NIH announcements
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
$200k
Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
$500k
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
$500k
The full announcement, free with an account
- The full announcement text, not just the first two sentences
- All 3 review criteria reviewers score this against, extracted from this announcement
On Plus, $39 a month
- The eligibility check against your profile: career stage, institution type, and the windows that close before the deadline does
- Funded precedents: what similar NIH projects received, from the award records in NIH RePORTER
- A Reviewer Scorecard of your draft against these criteria
More from National Institutes of Health
Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed)
Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed)
HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)
$375k
Cellular Senescence Network (SenNet): SenNet Data Coordination and Integration Center (SenNet DCIC) (UM1 Clinical Trials Not Allowed)
Related by subject
Cooperative Agreement for affiliated Partner with the Colorado Plateau Cooperative Ecosystem Studies Unit
$360k
Cooperative Agreement for affiliated Partner with Colorado Plateau Cooperative Ecosystem Studies Unit
$475k
Cooperative Agreement for affiliated Partner with the Great Plains Cooperative Ecosystem Studies Unit
$370k
Hiring in this research area now
- Technology-Driven Integrative Physiology AI-Enabled Cell, Molecular and Genomic Biol Asst/Assoc ProfSalary is commensurate with education and experience.
- Postdoctoral Research ScientistPost-doctoral Research Scientist -- Cancer Research
- Postdoctoral Position (f/m/d) in Computational Viral Genomics and EvolutionE 13 TV EntGO Bund